Hologic Inc. (HOLX)
Hologic Statistics
Share Statistics
Hologic has 224.39M shares outstanding. The number of shares has increased by -3.32% in one year.
Shares Outstanding | 224.39M |
Shares Change (YoY) | -3.32% |
Shares Change (QoQ) | -2.3% |
Owned by Institutions (%) | 97.83% |
Shares Floating | 222.48M |
Failed to Deliver (FTD) Shares | 61.28K |
FTD / Avg. Volume | 2.16% |
Short Selling Information
The latest short interest is 6.15M, so 2.72% of the outstanding shares have been sold short.
Short Interest | 6.15M |
Short % of Shares Out | 2.72% |
Short % of Float | 2.76% |
Short Ratio (days to cover) | 3.55 |
Valuation Ratios
The PE ratio is 24.13 and the forward PE ratio is 15.48. Hologic's PEG ratio is 0.3.
PE Ratio | 24.13 |
Forward PE | 15.48 |
PS Ratio | 4.73 |
Forward PS | 2.7 |
PB Ratio | 3.71 |
P/FCF Ratio | 16.64 |
PEG Ratio | 0.3 |
Enterprise Valuation
Hologic Inc. has an Enterprise Value (EV) of 17.22B.
EV / Earnings | 21.81 |
EV / Sales | 4.27 |
EV / EBITDA | 13.29 |
EV / EBIT | 17.75 |
EV / FCF | 15.04 |
Financial Position
The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.52.
Current Ratio | 3.69 |
Quick Ratio | 3.03 |
Debt / Equity | 0.52 |
Total Debt / Capitalization | 34.13 |
Cash Flow / Debt | 0.48 |
Interest Coverage | 7.95 |
Financial Efficiency
Return on equity (ROE) is 0.15% and return on capital (ROIC) is 11.37%.
Return on Equity (ROE) | 0.15% |
Return on Assets (ROA) | 0.09% |
Return on Capital (ROIC) | 11.37% |
Revenue Per Employee | $570,621.55 |
Profits Per Employee | $111,779.7 |
Employee Count | 7,063 |
Asset Turnover | 0.44 |
Inventory Turnover | 2.65 |
Taxes
Income Tax | 75.6M |
Effective Tax Rate | 0.09 |
Stock Price Statistics
The stock price has increased by -18.35% in the last 52 weeks. The beta is 0.97, so Hologic's price volatility has been higher than the market average.
Beta | 0.97 |
52-Week Price Change | -18.35% |
50-Day Moving Average | 66.51 |
200-Day Moving Average | 75.26 |
Relative Strength Index (RSI) | 36.97 |
Average Volume (20 Days) | 2.83M |
Income Statement
In the last 12 months, Hologic had revenue of 4.03B and earned 789.5M in profits. Earnings per share was 3.35.
Revenue | 4.03B |
Gross Profit | 2.23B |
Operating Income | 970.2M |
Net Income | 789.5M |
EBITDA | 1.3B |
EBIT | 970.2M |
Earnings Per Share (EPS) | 3.35 |
Balance Sheet
The company has 2.16B in cash and 2.66B in debt, giving a net cash position of -497.8M.
Cash & Cash Equivalents | 2.16B |
Total Debt | 2.66B |
Net Cash | -497.8M |
Retained Earnings | 0 |
Total Assets | 8.73B |
Working Capital | 2.49B |
Cash Flow
In the last 12 months, operating cash flow was 1.29B and capital expenditures -140.2M, giving a free cash flow of 1.15B.
Operating Cash Flow | 1.29B |
Capital Expenditures | -140.2M |
Free Cash Flow | 1.15B |
FCF Per Share | 4.86 |
Margins
Gross margin is 55.28%, with operating and profit margins of 24.07% and 19.59%.
Gross Margin | 55.28% |
Operating Margin | 24.07% |
Pretax Margin | 21.46% |
Profit Margin | 19.59% |
EBITDA Margin | 32.16% |
EBIT Margin | 24.07% |
FCF Margin | 28.41% |
Dividends & Yields
HOLX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 5.45% |
FCF Yield | 8.3% |
Analyst Forecast
The average price target for HOLX is $85, which is 38.3% higher than the current price. The consensus rating is "Hold".
Price Target | $85 |
Price Target Difference | 38.3% |
Analyst Consensus | Hold |
Analyst Count | 14 |
Stock Splits
The last stock split was on Apr 3, 2008. It was a forward split with a ratio of 2:1.
Last Split Date | Apr 3, 2008 |
Split Type | forward |
Split Ratio | 2:1 |
Scores
Altman Z-Score | 3.28 |
Piotroski F-Score | 8 |